SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


Speaker
Franck Rahaghi, MD, MHS, FCCP
Director, Advanced Lung Disease Clinic
Director, Pulmonary Hypertension Clinic
Chairman, Dept. of Pulmonary and Critical Care
Cleveland Clinic Florida
Weston, FL

Moderator
Deborah Paschal, CRNP
Clinical Nurse Practitioner
Philadelphia, PA

Title
: Finding the Needle in the Haystack: Diagnosing and Managing Alpha-1 Antitrypsin Deficiency in Patients with COPD
Activity/Course #:
: NCME363
Cost:
: Free
Release/Start Date:
: Oct 08 2018
Expiration Date:
: Oct 07 2019
Topics:
: Pulmonology
Target Audience:
: Primary Care Physicians, Nurse Practitioners, Physician Assistants
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.25 pharmacology hour(s)
Hardware/Software Requirements:
Program Summary:

Alpha-1 antitrypsin deficiency (AATD) is characterized by low serum levels of alpha-1 antitrypsin (AAT), a serine protease inhibitor responsible for inhibiting the proteolytic enzyme elastase. The clinical effects of AATD are most frequently found in the lungs, where AATD is associated with an increased risk of developing chronic obstructive pulmonary disease (COPD). Severe AATD poses a significant threat to health, with airflow obstruction being a major determinant of mortality. Over 250,000 individuals in the United States may have AATD, but the disease often remains unrecognized or undertreated.

This activity will explore the pathophysiology of Alpha-1 antitrypsin deficiency and its impact on COPD risk, strategies to enhance detection including the clinical significance of laboratory test results, and review the latest treatment options and GOLD guidelines and recommendations.

This webcast was recorded live at the Emerging Challenges in Primary Care Live Virtual Broadcast 2018 and is being used with the permission of the presenters.

Learning Objectives

After completing this program participants should be able to:

  1. Discuss the pathophysiology of Alpha-1 antitrypsin deficiency (AATD) and its impact on chronic obstructive pulmonary disease (COPD) risk.
  2. Interpret the clinical significance of laboratory test results for AATD.
  3. Discuss treatment options for AATD and latest GOLD guideline recommendations.
  4. Discuss strategies to enhance detection and treatment of AATD in clinical practice.

How to obtain the CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP accreditation statement
National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1 contact hours of continuing education which includes 0.25 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Speaker
Franck Rahaghi, MD, MHS, FCCP serves as a speaker/consultant and researcher for Shire. Dr. Rahaghi also serves as a speaker and consultant for Grifols.

Moderator
Deborah Paschal, CRNP, has no relationships to disclose.

Contributing Faculty
Robert A. Sandhaus, MD, PhD, FCCP serves as principal Investigator for NIH/NHLBI and MatRx.

Activity Planning Committee
Josh Kilbridge, Medical Writer, has no relationship to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has no relationships to disclose.

Gregg Sherman, MD, Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Sheila Lucas Activity Planning Committee has no relationships to disclose.

Sandy Bihlmeyer, MEd, Activity Planning Committee, has no relationship to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an educational grant from Grifols.